February 14, 2025 - 12:02

Hydrostor, a leader in long-duration energy storage, has successfully raised $200 million to advance its groundbreaking Advanced Compressed Air Energy Storage (A-CAES) technology. This significant funding aims to enhance the reliability of renewable energy sources by providing a robust solution to store energy generated from intermittent sources such as wind and solar.
The financing includes a substantial $150 million commitment through a convertible note from a consortium of investors, which notably features the Canada Growth Fund. This investment is poised to accelerate the development of Hydrostor's projects, allowing for greater energy resilience and sustainability in the face of growing energy demands.
With the global shift towards renewable energy, Hydrostor's innovative approach to energy storage is becoming increasingly vital. By harnessing compressed air technology, the company aims to provide a reliable and efficient means of storing excess energy, thus supporting a cleaner and more sustainable energy future. This funding marks a pivotal moment for Hydrostor as it continues to lead the charge in energy innovation.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...